The expression of cleaved Caspase-3 and cleaved PARP1 significantly increased after silibinin treatment, which means that silibinin induced cholangiocarcinoma cell death by activating apoptosis pathways (Figures 2D,E). Here, PARP1 is linked to cholangiocarcinoma.